ARTICLE | Clinical News
Synsorb drops Synsorb-Cd
December 10, 2001 8:00 AM UTC
Synsorb (TSE:SYB; SYBB) terminated development of Synsorb-Cd, an oligosaccharide coupled to an inert support that absorbs toxins in the intestine, which was in Phase III testing to prevent recurring C...